Advice on regulatory procedures for ATMPs that may be used during development (III): Stem cell-based medicinal products
Today, from Revio, we would like to share with you a summary of the main aspects mentioned in the EMA ‘’Reflection paper on stem cell-based medicinal products’’ (EMA/CAT/571134/2009) which may…
